Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

17.01
+0.14000.83%
Post-market: 17.010.00000.00%19:30 EDT
Volume:1.16M
Turnover:19.63M
Market Cap:5.43B
PE:35.38
High:17.11
Open:17.00
Low:16.73
Close:16.87
52wk High:19.26
52wk Low:9.49
Shares:319.00M
Float Shares:191.00M
Volume Ratio:0.66
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4808
EPS(LYR):0.2200
ROE:613.02%
ROA:8.60%
PB:164.31
PE(LYR):77.32

Loading ...

Amneal Pharmaceuticals Price Target Announced at $23.00/Share by Leerink Partners

Dow Jones
·
Sep 09

Leerink Partners Initiates Coverage on Amneal Pharmaceuticals With Outperform, $23 Price Target

MT Newswires Live
·
Sep 09

Amneal Pharmaceuticals initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

U.S. Research Roundup-Argan, Mastec, Oracle

Reuters
·
Sep 09

Amneal Pharma: Selling Stockholders May Offer & Sell from Time to Time up to 28,942,098 Shares of Class a Common Stock- SEC Filing

THOMSON REUTERS
·
Sep 04

Amneal Pharmaceuticals Price Target Announced at $22.00/Share by JP Morgan

Dow Jones
·
Aug 26

U.S. Research Roundup- Intuit, MongoDB, Zscaler

Reuters
·
Aug 26

Amneal Pharma : JP Morgan Resumes Coverage with Overweight Rating; Target Price $22

THOMSON REUTERS
·
Aug 26

Amneal EVP, Chief Legal Officer Jason B. Daly Sells USD 3.77 Million in Common Shares

Reuters
·
Aug 14

Amneal Completes Acquisition of Kashiv BioSciences

Reuters
·
Aug 10

Amneal Completes Acquisition of Kashiv Biosciences, Creating a Global Biosimilar Leader

THOMSON REUTERS
·
Aug 10

Amneal Pharmaceuticals' (NASDAQ:AMRX) Strong Earnings Are Of Good Quality

Simply Wall St.
·
Aug 07

Amneal Pharmaceuticals - Converts Term Loans to $2.04 Bln; Incurs New $45.20 Mln Term Loan - SEC Filing

THOMSON REUTERS
·
Aug 04

Amneal Reprices Term Loan, Cuts Interest Margin 50 Bps on USD 2.08 Billion Facility

Reuters
·
Aug 04

Amneal Pharmaceuticals is Maintained at Buy by UBS

Dow Jones
·
Aug 04

Amneal Pharmaceuticals Has Favorable Setup for Growth With Product Approvals, Launches, UBS Says

MT Newswires Live
·
Aug 04

UBS Adjusts Price Target on Amneal Pharmaceuticals to $25 From $23, Maintains Buy Rating

MT Newswires Live
·
Aug 03

Did Strong Q2 Results and Higher 2026 Revenue Guidance Just Shift Amneal Pharmaceuticals' (AMRX) Investment Narrative?

Simply Wall St.
·
Aug 03

Amneal Pharmaceuticals Held Special Shareholder Meeting on Kashiv BioSciences Deal

Reuters
·
Aug 01

Amneal Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31